Despite the market’s recent drop brought on by concerns over escalating trade tensions between the U.S. and China, it is hard for investors to find value plays amongst stocks. There is, however, still value to be had – and today’s article highlights three undervalued stocks to consider. Among them is a mid-cap stock carving out a niche in what the author notes “is the fastest-growing space within the pharmaceutical industry”: oncology. For more on these three value stocks, CLICK HERE.
stocks
Why The Recent Yield Curve Inversion Is A Positive Sign For Stocks
The yield curve was the focus of much attention – and the source of much concern – when it inverted last month. After all, an inversion of the yield curve has preceded every recession over the past 50 years. However, while the yield curve inverting may be a worrying economic sign, the author of today’s article notes that, while a recession is coming, history indicates it’s not coming tomorrow. Moreover, he asserts that “The recent yield curve inversion is a positive sign for stocks, at least for now.” Why? CLICK HERE.
Straight Talk On Buying Stocks Directly
How can you buy stock directly and bypass using a broker (and paying said broker commission)? With dividend reinvestment plans (DRIPs) – which are being offered by an ever-increasing number of companies. Today’s article highlights “an excellent source of information for those who want to know how to buy stock directly and which companies offer this opportunity” and examines what to be careful of when buying stock directly, who should (and should not) buy stock directly, and more. CLICK HERE.
Pass On Pot Stocks?
Tilray, Canopy Growth, Cronos Group and Aurora Cannabis are among the most well-known names among investors in the cannabis space. However, the author of today’s article argues that while “Overall, the longer-term future of the [cannabis] industry actually appears positive as the inevitable consolidations and acquisitions shake-out the weaker players and help build much larger, stronger cannabis companies…that does not mean now is necessarily a good time to buy those stocks.” For his fundamental and technical analysis of these four pot stocks, CLICK HERE.
Solid Dividend Growth Stocks vs. “Accidental High-Yielders”
“The biggest mistake dividend investors make is confusing a high-yield stock for a growing-yield stock,” advises a chief investment officer cited in today’s article. In order to separate out strong dividend growth stock picks from “accidental high-yielders”, the author screened for stocks sporting higher yields than the S&P 500 and with better forecasted dividend growth. For six dividend stocks that met these criteria, CLICK HERE.
The Historical Template That Is “Table-Pounding Bullish” For Gold Stocks
Based on one historical template, the trend for gold stocks is “table-pounding bullish”, notes today’s article. That historical template? The recovery from a “mega bear market”, which the author describes this way: “Following the bear market low, a sharp rally begins that lasts only six to twelve months. Then the market endures a significant correction that lasts a minimum of 18 months and ends with a breakdown to new lows (which ends up being a false move). Then the major wave higher begins.” What are some past examples of this template playing out – and what does it indicate about gold stocks in the near-term? CLICK HERE.
The Many ETF Paths To Income
“Whether your focus is big companies or small, domestic corporations or international ones, there are ETFs where income-oriented investors can find investments that pay more than the average S&P 500 index component,” notes the author of today’s article – who proceeds to highlight nine income-focused ETFs which, while focusing on different categories of stocks (e.g. large-cap, preferred, low-volatility) and employing different strategies (e.g. current dividend yield vs. dividend growth) offer above-average dividends. For more, CLICK HERE.
Which Stock Wins Wall Street’s Battle Of The “Cannabis Contenders”?
Which of the top cannabis stocks listed in the U.S. is the consensus favorite of Wall Street? Today’s article ranks the top “cannabis contenders” (including Canopy Growth, Aurora Cannabis, Tilray and Zynerba Pharmaceuticals) based on analyst ratings and upside potential – and while it comes down to a close race between two cannabis stocks, one stock is ultimately singled out as Wall Street’s favorite to buy. For more, CLICK HERE.
Reaching The “Magical” Dividend Crossover Point
For dividend investors looking to achieve financial independence, the author of today’s article notes that the key is reaching the dividend crossover point – “The magic point…where the dividend income exceeds the expenses of the dividend investor”. Reaching the dividend crossover point isn’t easy, however, and the author identifies the key ingredients to doing so, as well as some rules to follow “in order to create s sustainable dividend producing machine, which would produce dependable income for decades.” For more,
CLICK HERE.
What Happens When The Stock Buyback Party Ends?
Debt-funded stock buybacks have been on the rise since 2009, with 2018 seeing a record amount of buyback activity. This leads the author of today’s article to make the following point: “If the stock market performed as poorly as it did in 2018 with record amounts of buybacks to prop it up, just imagine how much worse it would be if buybacks were to slow down significantly or grind to a halt?” For his insights on what a bursting of the U.S. corporate debt bubble could mean for stocks, CLICK HERE.